美国卒中人群中符合血管内治疗条件的患者数量预测
该研究基于GCNKSS 2015年人群横断面观察数据,将符合血管内取栓(EVT)条件的急性缺血性卒中患者比例外推至2020年美国成人人口。估算2020年美国有8659至17219例患者符合现行指南EVT标准,若扩大适应症(大核心梗死、轻型卒中、病前残疾等),符合条件的患者数可增至36562至73174例,约为现行标准的4倍。
要点
- 2020年美国符合现行指南EVT标准的成人患者估计为8659至17219例。
- 扩大EVT适应症后,符合条件人群可增至36562至73174例,约为现行标准的4倍。
- 美国卒中系统需快速优化以应对所有符合EVT条件的卒中患者。
核心结论
- 2020年美国约有8659至17219例成人患者符合严格的EVT纳入标准。
- 随着近期或未来阳性试验的逐步采纳,基于人群的EVT合格患者数预计可增加4倍。
- 美国卒中系统需要快速优化以处理所有符合EVT条件的卒中患者。
研究设计与样本
- 对GCNKSS(大辛辛那提北肯塔基卒中研究)2015年数据行事后分析,该研究为基于人群的横断面观察性研究,覆盖5个县。
- 纳入所有≥18岁急性缺血性卒中住院患者,通过ICD-9编码430-436及ICD-10编码I60-I67和G45-G46确定,并外推至2020年美国成人人口普查数据。
- 基于最后已知正常至就诊时间(0-5小时 vs 5-23小时)、就诊时NIHSS评分及病前mRS确定GCNKSS人群中EVT合格率。
- 大血管闭塞和大核心梗死的患病率采用文献综述的保守和宽松估计(2015年GCNKSS中不可用)。
- 2015年GCNKSS成人1,057,183例中,2741例发生缺血性卒中,2176例有可用分析数据。
主要发现
- 2020年美国符合现行指南推荐EVT标准(非大核心、无病前残疾、NIHSS评分≥6)的患者估计为8659至17219例(保守至宽松估计)。
- 扩大EVT合格亚组估计(保守至宽松):大核心梗死为5316至10635例;就诊时轻型缺损(低NIHSS评分)为10635至21270例;病前残疾较高为13572至27089例;符合>1项标准为7039至14180例。
- 上述扩大合格亚组合计为36562至73174例患者。
关键数值与推荐
- 现行指南推荐EVT标准:非大核心梗死、无病前残疾、NIHSS评分≥6。
- 扩大EVT合格亚组包括:大核心梗死、就诊时轻型缺损(低NIHSS评分)、病前残疾较高、符合>1项标准。
临床怎么用
- 原文未据此给出推荐。
局限性
- 2015年GCNKSS中无法获得大血管闭塞和大核心梗死的患病率,因此采用了基于文献综述的保守和宽松估计。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As stroke endovascular thrombectomy (EVT) treatment indications expand, understanding population-based EVT eligibility becomes critical for resource planning. We aimed to project current and future population-based EVT eligibility in the United States. METHODS: We conducted a post hoc analysis of the physician-adjudicated GCNKSS (Greater Cincinnati Northern Kentucky Stroke Study; 2015 epoch), a population-based, cross sectional, observational study of stroke incidence, treatment, and outcomes across a 5-county region. All hospitalized patients ≥18 years of age with acute ischemic stroke were ascertained using the International Classification of Diseases, Ninth Revision codes 430-436 and Tenth Revision codes I60-I67 and G45-G46 and extrapolated to the US adult census 2020. We determined the rate of EVT eligibility within the GCNKSS population using time from last known well to presentation (0-5 versus 5-23 hours), presenting National Institutes of Health Stroke Scale, and prestroke modified Rankin Scale. Both conservative and liberal estimates of prevalence of large vessel occlusion and large core were then applied based on literature review (unavailable within the 2015 GCNKSS). This eligibility was then extrapolated to the 2020 US population. RESULTS: Of the 1 057 183 adults within GCNKSS in 2015, 2741 had an ischemic stroke and 2176 had data available for analysis. We calculated that 8659 to 17 219 patients (conservative to liberal) meet the current guideline-recommended EVT criteria (nonlarge core, no prestroke disability, and National Institutes of Health Stroke Scale score ≥6) in the United States. Estimates (conservative to liberal) for expanded EVT eligibility subpopulations include (1) 5316 to 10 635 by large core; (2) 10 635 to 21 270 by mild presenting deficits with low National Institutes of Health Stroke Scale score; (3) 13 572 to 27 089 by higher prestroke disability; and (4) 7039 to 14 180 by >1 criteria. These expanded eligibility subpopulations amount to 36 562 to 73 174 patients. CONCLUSIONS: An estimated 8659 to 17 219 adult patients in the United States met strict EVT eligibility criteria in 2020. A 4-fold increase in population-based EVT eligibility can be anticipated with incremental adoption of recent or future positive trials. US stroke systems need to be rapidly optimized to handle all EVT-eligible patients with stroke.
引用
- Mistry EA, Khoury JC, Kleindorfer DO, et al. Projections of Endovascular Therapy-Eligible Patients With Stroke for the US Population. Stroke. 2024. PMID: 38934124. doi:10.1161/STROKEAHA.123.045766
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。